Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.96 HKD | -0.14% |
|
-4.25% | -53.31% |
06-03 | ImmuneOnco Biopharmaceuticals Gets China's Phase 3 Trial Approval for Leukemia Drug | MT |
05-30 | ImmuneOnco Completes Filing with China Regulator for Conversion of H Shares | MT |
- Stock Market
- Equities
- 1541 Stock
- News ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- MarketScreener Strategies